APA (7th ed.) Citation

Kaito Mimura, Akihiko Shimomura, Tomoko Gota, Kenju Ando, Yukino Kawamura, Tomoko Taniyama, . . . Chikako Shimizu. (2022). Response to lenvatinib and pembrolizumab combination therapy in pembrolizumab-pretreated relapsed endometrial cancer. Elsevier.

Chicago Style (17th ed.) Citation

Kaito Mimura, Akihiko Shimomura, Tomoko Gota, Kenju Ando, Yukino Kawamura, Tomoko Taniyama, Hajime Oishi, and Chikako Shimizu. Response to Lenvatinib and Pembrolizumab Combination Therapy in Pembrolizumab-pretreated Relapsed Endometrial Cancer. Elsevier, 2022.

MLA (9th ed.) Citation

Kaito Mimura, et al. Response to Lenvatinib and Pembrolizumab Combination Therapy in Pembrolizumab-pretreated Relapsed Endometrial Cancer. Elsevier, 2022.